Jane Street’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
56,981
+27,630
| +94% | +$554K | ﹤0.01% | 2713 |
|
|
2025
Q1 | $578K | Buy |
+29,351
| New | +$578K | ﹤0.01% | 3752 |
|
|
2024
Q4 | – | Sell |
-30,793
| Closed | -$786K | – | 6021 |
|
|
2024
Q3 | $786K | Sell |
30,793
-22,212
| -42% | -$567K | ﹤0.01% | 3721 |
|
|
2024
Q2 | $1.24M | Buy |
53,005
+42,603
| +410% | +$996K | ﹤0.01% | 3380 |
|
|
2024
Q1 | $183K | Sell |
10,402
-5,282
| -34% | -$92.9K | ﹤0.01% | 5069 |
|
|
2023
Q4 | $217K | Buy |
+15,684
| New | +$217K | ﹤0.01% | 4942 |
|
|
2023
Q3 | – | Sell |
-10,531
| Closed | -$215K | – | 5271 |
|
|
2023
Q2 | $215K | Sell |
10,531
-7,913
| -43% | -$162K | ﹤0.01% | 4539 |
|
|
2023
Q1 | $404K | Buy |
+18,444
| New | +$404K | ﹤0.01% | 3904 |
|
|
2020
Q3 | – | Sell |
-2,835
| Closed | -$314K | – | 3901 |
|
|
2020
Q2 | $314K | Buy |
+2,835
| New | +$314K | ﹤0.01% | 2997 |
|